D. Boral Capital Reaffirms “Buy” Rating for Anixa Biosciences (NASDAQ:ANIX)
Anixa Biosciences (NASDAQ:ANIX – Get Free Report)‘s stock had its “buy” rating reissued by stock analysts at D. Boral Capital in a report released on Thursday,Benzinga reports. They presently have a $10.00 price objective on the stock. D. Boral Capital’s target price suggests a potential upside of 289.11% from the stock’s previous close. ANIX has […]
Anixa Biosciences (NASDAQ:ANIX – Get Free Report)‘s stock had its “buy” rating reissued by stock analysts at D. Boral Capital in a report released on Thursday,Benzinga reports. They presently have a $10.00 price objective on the stock. D. Boral Capital’s target price suggests a potential upside of 289.11% from the stock’s previous close. ANIX has […]
